Investors were tripping over themselves to buy Dr Martens (DOCS) after the iconic British footwear brand announced a return to profit growth. FY26 results confirmed the footwear retailer’s Levers for Growth strategy is gaining traction. Reduced discounting and a pivot to a ‘truly consumer-first’ business model are paying off for the FTSE 250 firm. Positive strides Dr … Continue reading Dr Martens returns to profit growth